These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6889965)

  • 1. What do early bone scans tell about breast cancer patients?
    Rossing N; Munck O; Nielsen SP; Andersen KW
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):629-36. PubMed ID: 6889965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone metastases in primary operable breast cancer. The role of serial scintigraphy.
    Thomsen HS; Lund JO; Munck O; Andersen KW; Støckel M; Rossing N
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1019-23. PubMed ID: 6540684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of patients with breast cancer for routine follow-up bone scans.
    Coleman RE; Fogelman I; Habibollahi F; North WR; Rubens RD
    Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):328-32. PubMed ID: 2278890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Staging of patients with carcinoma of the breast by bone scans? [author's transl)].
    Creutzig H
    Radiologe; 1978 May; 18(5):179-83. PubMed ID: 652985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
    Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
    Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of bone scans in an adjuvant breast cancer program.
    Hammond N; Jones SE; Salmon SE; Patton D; Woolfenden J
    Cancer; 1978 Jan; 41(1):138-42. PubMed ID: 626924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide bone scan in initial staging of breast cancer.
    Boughattas S; Hassine H; Chatti K; Essabbah H
    Tunis Med; 2003 Mar; 81(3):156-61. PubMed ID: 12793064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer.
    Khansur T; Haick A; Patel B; Balducci L; Vance R; Thigpen T
    Am J Clin Oncol; 1987 Apr; 10(2):167-70. PubMed ID: 3565316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up.
    Butzelaar RM; van Dongen JA; de Graaf PW; van der Schoot JB
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):877-80. PubMed ID: 6540189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for selective use of bone scans in early stage breast cancer.
    Hadley D; Fowble B; Torosian MH
    Oncol Rep; 1998; 5(4):991-3. PubMed ID: 9625860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and outcome of one or two rib lesions on bone scans in breast cancer patients without known metastases.
    Chen HH; Su WC; Guo HR; Lee BF; Su WR; Wu PS; Chiu NT
    Nucl Med Commun; 2003 Nov; 24(11):1167-74. PubMed ID: 14569171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural history of cancer of the breast. Probability of developing bone metastases].
    Polico C; Saladini G; Casara D; Tomio L; Sotti G
    Radiol Med; 1987 May; 73(5):414-6. PubMed ID: 3589016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential bone scans and chest radiographs in the postoperative management of early breast cancer.
    Chaudary MA; Maisey MN; Shaw PJ; Rubens RD; Hayward JL
    Br J Surg; 1983 Sep; 70(9):517-8. PubMed ID: 6616153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone scanning: its lack of value in the follow-up of patients with breast cancer.
    Bishop HM; Blamey RW; Morris AH; Rose DH; Preston B; Lane J; Doyle PJ
    Br J Surg; 1979 Oct; 66(10):752-4. PubMed ID: 509054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer.
    Van Den Bossche B; D'haeninck E; De Winter F; Van Belle S; Dierckx RA; Van De Wiele C
    Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of the baseline bone scan in breast cancer.
    Coleman RE; Rubens RD; Fogelman I
    J Nucl Med; 1988 Jun; 29(6):1045-9. PubMed ID: 3373314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost efficiency of bone scans in breast cancer.
    Kennedy H; Kennedy N; Barclay M; Horobin M
    Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):73-7. PubMed ID: 1903301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of a positive baseline bone scan in breast cancer.
    Ho YY; Chan YH
    Australas Radiol; 2005 Feb; 49(1):21-6. PubMed ID: 15727605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM; Wright DJ
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.